Osaic Holdings
EW icon

Osaic Holdings’s Edwards Lifesciences EW Stock Holding History

Osaic Holdings’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4
Closed -$1.57K – 7479
2024
Q3 		$1.57K Buy
+4
New +$291 ﹤0.01% 6700

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Osaic Holdings's EW Position: Q1 2026 in Review

Osaic Holdings reduced its Edwards Lifesciences (EW) stake by 4.1% in Q1 2026, selling an estimated $147K and leaving 41,416 shares worth $3.32M. The position accounts for ﹤0.01% of the portfolio, ranked #1657.

Osaic Holdings first reported a position in EW in Q1 2020 and has held it in 25 quarters since. The position peaked at $28.9M in Q4 2021. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Osaic Holdings held 41,416 shares of Edwards Lifesciences worth $3.32M as of Q1 2026.
  • Osaic Holdings sold 1,786 Edwards Lifesciences shares in Q1 2026, an estimated $147K.
  • Edwards Lifesciences made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #1657 holding.
  • Osaic Holdings first reported a position in Edwards Lifesciences in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Edwards Lifesciences position peaked at $28.9M in Q4 2021.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.